Lamy PJ - Search Results

1

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Jacquemier J, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F. Jacquemier J, et al. Among authors: lamy pj. BMC Cancer. 2013 Jul 22;13:351. doi: 10.1186/1471-2407-13-351. BMC Cancer. 2013. PMID: 23875536 Free PMC article.

2

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles.

Jacot W, Lopez-Crapez E, Thezenas S, Senal R, Fina F, Bibeau F, Romieu G, Lamy PJ. Jacot W, et al. Among authors: lamy pj. Breast Cancer Res. 2011;13(6):R133. doi: 10.1186/bcr3079. Epub 2011 Dec 22. Breast Cancer Res. 2011. PMID: 22192147 Free PMC article.

3

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.

Jacot W, Thezenas S, Senal R, Viglianti C, Laberenne AC, Lopez-Crapez E, Bibeau F, Bleuse JP, Romieu G, Lamy PJ. Jacot W, et al. Among authors: lamy pj. BMC Cancer. 2013 Nov 5;13:523. doi: 10.1186/1471-2407-13-523. BMC Cancer. 2013. PMID: 24191908 Free PMC article.

4

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

Lamy PJ, Castan F, Lozano N, Montélion C, Audran P, Bibeau F, Roques S, Montels F, Laberenne AC. Lamy PJ, et al. J Mol Diagn. 2015 Jul;17(4):366-73. doi: 10.1016/j.jmoldx.2015.02.004. Epub 2015 May 5. J Mol Diagn. 2015. PMID: 25952101 Free article.

5

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].

Luporsi E, Bellocq JP, Barrière J, Bonastre J, Chetritt J, Le Corroller AG, de Cremoux P, Fina F, Gauchez AS, Lamy PJ, Martin PM, Mazouni C, Peyrat JP, Romieu G, Verdoni L, Mazeau-Woynar V, Kassab-Chahmi D; Institut National du Cancer. Luporsi E, et al. Among authors: lamy pj. Bull Cancer. 2015 Sep;102(9):719-29. doi: 10.1016/j.bulcan.2015.05.003. Epub 2015 Jul 30. Bull Cancer. 2015. PMID: 26235416 Free article. French. No abstract available.

6

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.

Jacot W, Mollevi C, Fina F, Lopez-Crapez E, Martin PM, Colombo PE, Bibeau F, Romieu G, Lamy PJ. Jacot W, et al. Among authors: lamy pj. BMC Cancer. 2015 Dec 18;15:986. doi: 10.1186/s12885-015-1977-3. BMC Cancer. 2015. PMID: 26680641 Free PMC article.

7

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.

Darlix A, Lamy PJ, Lopez-Crapez E, Braccini AL, Firmin N, Romieu G, Thezenas S, Jacot W. Darlix A, et al. Among authors: lamy pj. BMC Cancer. 2016 Jul 7;16:428. doi: 10.1186/s12885-016-2448-1. BMC Cancer. 2016. PMID: 27387327 Free PMC article.

8

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma.

Lehmann-Che J, Miquel C, Wong J, Callens C, Rouleau E, Quillien V, Lozano N, Cayre A, Lacroix L, Bieche I, Bertheau P, Teixeira L, Penault-Llorca F, Lamy PJ, DE Cremoux P; GFCO GROUP. Lehmann-Che J, et al. Among authors: lamy pj. Anticancer Res. 2018 May;38(5):2909-2914. doi: 10.21873/anticanres.12538. Anticancer Res. 2018. PMID: 29715116

9

HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer.

Tsé C, Gauchez AS, Jacot W, Lamy PJ. Tsé C, et al. Among authors: lamy pj. Cancer Treat Rev. 2012 Apr;38(2):133-42. doi: 10.1016/j.ctrv.2011.03.008. Epub 2011 May 5. Cancer Treat Rev. 2012. PMID: 21549508 Review.

10

KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment.

Boissière-Michot F, Lopez-Crapez E, Frugier H, Berthe ML, Ho-Pun-Cheung A, Assenat E, Maudelonde T, Lamy PJ, Bibeau F. Boissière-Michot F, et al. Among authors: lamy pj. Mod Pathol. 2012 May;25(5):731-9. doi: 10.1038/modpathol.2011.210. Epub 2012 Jan 27. Mod Pathol. 2012. PMID: 22282307 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters